Cargando…

Selective 5HT3 antagonists and sensory processing: a systematic review

Ondansetron is a selective serotonin (5HT3) receptor antagonist that is under evaluation as an adjunctive treatment for schizophrenia, and a novel treatment for hallucinations in Parkinson’s disease. Ondansetron reverses sensory gating deficits and improves visuoperceptual processing in animal model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsitsipa, Eirini, Rogers, Jonathan, Casalotti, Sebastian, Belessiotis-Richards, Clara, Zubko, Olga, Weil, Rimona S., Howard, Robert, Bisby, James A., Reeves, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882165/ https://www.ncbi.nlm.nih.gov/pubmed/35017671 http://dx.doi.org/10.1038/s41386-021-01255-4

Ejemplares similares

Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
por: Weil, Rimona S, et al.
Publicado: (2020)

Disrupted reward processing in Parkinson’s disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis
por: Costello, Harry, et al.
Publicado: (2022)

The neurocognitive functioning in bipolar disorder: a systematic review of data
por: Tsitsipa, Eirini, et al.
Publicado: (2015)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.
por: Cassidy, J., et al.
Publicado: (1988)

A new taxonomy for perceptual filling-in
por: Weil, Rimona S., et al.
Publicado: (2011)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

A Pair of Partially Overlapping Arabidopsis Genes with Antagonistic Circadian Expression
por: Kunova, Andrea, et al.
Publicado: (2012)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

Sustainable Synthesis of a Potent and Selective 5-HT(7) Receptor Antagonist Using a Mechanochemical Approach
por: Canale, Vittorio, et al.
Publicado: (2020)

Functional group interactions of a 5-HT(3)R antagonist
por: Venkataraman, Padmavati, et al.
Publicado: (2002)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Superiority of the Triple-Acting 5-HT(6)R/5-HT(3)R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT(6)R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
por: Grychowska, Katarzyna, et al.
Publicado: (2023)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT(1A) and 5-HT(7) Antagonists in Animal Models
por: Pytka, Karolina, et al.
Publicado: (2015)

Extended N-Arylsulfonylindoles as 5-HT(6) Receptor Antagonists: Design, Synthesis & Biological Evaluation
por: Vera, Gonzalo, et al.
Publicado: (2016)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

The Computational, Pharmacological, and Physiological Determinants of Sensory Learning under Uncertainty
por: Lawson, Rebecca P., et al.
Publicado: (2021)

Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
por: Zarkali, Angeliki, et al.
Publicado: (2022)

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.
por: de Boer-Dennert, M., et al.
Publicado: (1997)

Distribution of cells responsive to 5-HT(6) receptor antagonist-induced hypophagia
por: Garfield, Alastair S., et al.
Publicado: (2014)

Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
por: Gilmore, James, et al.
Publicado: (2018)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Current position of 5HT(3) antagonists and the additional value of NK(1) antagonists; a new class of antiemetics
por: de Wit, R
Publicado: (2003)

Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
por: Nikiforuk, Agnieszka, et al.
Publicado: (2013)

Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson’s Disease
por: Zarkali, Angeliki, et al.
Publicado: (2019)

Psychosocial treatment and interventions for bipolar disorder: a systematic review
por: Miziou, Stella, et al.
Publicado: (2015)

Harnessing mechanical instabilities at the nanoscale to achieve ultra-low stiffness metals
por: Reeve, Samuel Temple, et al.
Publicado: (2017)

Dual 5-HT(3) and 5-HT(6) Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
por: Castañé, Anna, et al.
Publicado: (2022)

Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2017)

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

htSNPer1.0: software for haplotype block partition and htSNPs selection
por: Ding, Keyue, et al.
Publicado: (2005)

Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
por: Kotańska, Magdalena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4pd83qfqde326upf4v1kq93lc3